RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases
Snahel Patel(Gene Therapy Laboratory), Domagoj Vucic(Gene Therapy Laboratory)
Cited by 145
Related Papers
c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor α (TNFα)-induced NF-κB Activation
|Journal of Biological Chemistry|2008|536
RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury
|Cell Death and Differentiation|2016|439
The Balance of TNF Mediated Pathways Regulates Inflammatory Cell Death Signaling in Healthy and Diseased Tissues
|Frontiers in Cell and Developmental Biology|2020|359
c‐IAP1 and UbcH5 promote K11‐linked polyubiquitination of RIP1 in TNF signalling
|The EMBO Journal|2010|338
Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling
|Cell Death and Differentiation|2017|130